Evaluation of intrauterine injection of recombinant human chorionic gonadotropin at different doses in improvement of pregnancy rates in in vitro fertilization/intracytoplasmic sperm injectio
Not Applicable
- Conditions
- Female Infertility.Female Infertility
- Registration Number
- IRCT2015020921008N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 420
Inclusion Criteria
The inclusion criteria: female age under 40 years old with infertility. Exclusion criteria: previous IVF/ICSI trials, including a successful trial, endometriosis, azoospermia, uterine myoma or previous myomectomy, or the existence of hydrosalpinges.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Implantation rate. Timepoint: two weeks after embryo transfer. Method of measurement: conventional pregnancy test.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy rate. Timepoint: three weeks after a positive pregnancy test. Method of measurement: ultrasound.